These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17508301)

  • 1. [Use of specific drugs for Alzheimer's disease].
    Villar Fernández I; Rabaneque Hernández MJ; Armesto Gómez J; García Arilla E; Izuel Rami M
    Neurologia; 2007 Jun; 22(5):275-84. PubMed ID: 17508301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in the prescription of cholinesterase inhibitors and memantine.
    Villar-Fernández I; Bjerrum L; Feja C; Rabanaque MJ
    Dement Geriatr Cogn Disord; 2009; 28(4):373-9. PubMed ID: 19887800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consumption trends for specific drugs used to treat dementia in the region of Madrid (Spain) from 2002 to 2012.
    de Hoyos-Alonso MC; Tapias-Merino E; Meseguer Barros CM; Sánchez-Martínez M; Otero A
    Neurologia; 2015 Sep; 30(7):416-24. PubMed ID: 24704249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of memantine in community-based Alzheimer's disease patients: An adaptation in Spain.
    Antonanzas F; Rive B; Badenas JM; Gomez-Lus S; Guilhaume C
    Eur J Health Econ; 2006 Jun; 7(2):137-44. PubMed ID: 16670912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of antihypertensive drugs in Spain (1995-2001)].
    García del Pozo J; Ramos Sevillano E; de Abajo FJ; Mateos Campos R
    Rev Esp Cardiol; 2004 Mar; 57(3):241-9. PubMed ID: 15056428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of antihypertensive drugs in Spain, 1985-1995].
    Prieto M; de Abajo FJ; Montero D; Martín-Serrano G; Madurga M; Palop R
    Med Clin (Barc); 1998 Feb; 110(7):247-53. PubMed ID: 9562948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Consumption and cost of antipsychotic drugs].
    Pérez J; Marín N; Vallano A; Castells X; Capellà D
    Actas Esp Psiquiatr; 2005; 33(2):110-6. PubMed ID: 15768318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of donepezil for mild to moderate Alzheimer's disease in Taiwan.
    Fuh JL; Wang SJ
    Int J Geriatr Psychiatry; 2008 Jan; 23(1):73-8. PubMed ID: 17520661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.
    Lopez-Bastida J; Serrano-Aguilar P; Perestelo-Perez L; Oliva-Moreno J
    Neurology; 2006 Dec; 67(12):2186-91. PubMed ID: 17190942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The action of memantine on the cognitive disorders of patients with dementia: reflections following two years' experience in Spain].
    Robles-Bayón A
    Rev Neurol; 2006 Mar 1-15; 42(5):288-96. PubMed ID: 16538592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of memantine in moderate and severe Alzheimer's disease in Norway.
    Rive B; Aarsland D; Grishchenko M; Cochran J; Lamure M; Toumi M
    Int J Geriatr Psychiatry; 2012 Jun; 27(6):573-82. PubMed ID: 21834130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-lowering drugs: use and expenditure in Portugal (1995-2004).
    Teixeira IJ; Escoval A; Schiappa M
    Rev Port Cardiol; 2007 May; 26(5):475-93. PubMed ID: 17691275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice?
    Tinklenberg JR; Kraemer HC; Yaffe K; Ross L; Sheikh J; Ashford JW; Yesavage JA; Taylor JL
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):953-60. PubMed ID: 17974866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease: emerging noncholinergic treatments.
    Geriatrics; 2003 Feb; 58 Suppl():3-14, inside back cover. PubMed ID: 12599937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-hypertensive drug utilization in Continental Portugal (1999-2004).
    Furtado C; Pinto M
    Rev Port Cardiol; 2006 Mar; 25(3):273-92. PubMed ID: 16789402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
    Sakka P; Tsolaki M; Hort J; Hager K; Soininen H; López Pousa S; Li C; Schwam E
    Curr Med Res Opin; 2007 Dec; 23(12):3153-65. PubMed ID: 17988434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis.
    Gauthier S; Loft H; Cummings J
    Int J Geriatr Psychiatry; 2008 May; 23(5):537-45. PubMed ID: 18058838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of current Alzheimer's disease treatments: a descriptive review.
    Cummings JL; Mackell J; Kaufer D
    Alzheimers Dement; 2008 Jan; 4(1):49-60. PubMed ID: 18631950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health service utilization among Alzheimer's disease patients: evidence from managed care.
    Frytak JR; Henk HJ; Zhao Y; Bowman L; Flynn JA; Nelson M
    Alzheimers Dement; 2008 Sep; 4(5):361-7. PubMed ID: 18790463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Benzodiazepine's utilization in continental Portugal (1999-2003)].
    Furtado C; Teixeira I
    Acta Med Port; 2006; 19(3):239-46. PubMed ID: 17234086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.